Two drugs developed by Disc Medicine (IRON) and Sanofi (SNY) are facing delays in their review timelines due to safety and ...

Reoperation rates between cervical disc replacement and anterior cervical discectomy and fusion didn’t see significant differences in reoperation risks. However disc replacement had some advantage in ...

Degenerative disc disease (DDD) and intervertebral disc degeneration (IVDD) represent conditions that impair the function of the spinal motion segments, profoundly affecting quality of life worldwide.

Findings from an interim analysis showed CELZ-201-DDT statistically significantly reduced pain and improved mobility in patients with chronic lower back pain. The Food and Drug Administration (FDA) ...

Disc Medicine (IRON) has made great progress in advancing its lead candidate for its pipeline known as bitopertin for the treatment of patients with erythropoietic protoporphyria [EPP] and X-linked ...

FSdC demonstrated statistically significant and superior improvement in disc preservation and structural integrity compared to other treatmentsHOUSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- FibroBiologics ...

According to Coherent Market Insights, the global degenerative disc disease treatment market was valued at US$ 1,736.4 million in 2019 and is expected to exhibit a CAGR of 9.0% over the forecast ...

Backed by more than three decades of clinical evidence and innovation, the prodisc platform continues to advance total disc ...

In summary, three randomized trials have compared cervical disc replacement to spinal fusion. At two year follow-up, cervical disc replacement appears to be not inferior to fusion for several relevant ...